Literature DB >> 12401396

Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression.

Chang H Kim1, Eugene C Butcher, Brent Johnston.   

Abstract

CD1d-restricted T-cell receptor Valpha-invariant natural killer T (NKT) cells are important regulators of immune responses through their efficient secretion of T helper 1 (Th1) and Th2 cytokines. Recently, it has been shown that this NKT-cell population contains functionally distinct subsets, producing different sets of cytokines and cytotoxic effector molecules. NKT-cell subsets are also distinct from each other in their expression of adhesion molecules and chemokine receptors, suggesting that they might be targeted to different tissues and perform different immune functions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401396     DOI: 10.1016/s1471-4906(02)02323-2

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  40 in total

1.  Immunoregulatory defects of V alpha 24V+ beta 11+ NKT cells in development of Wegener's granulomatosis and relapsing polychondritis.

Authors:  D Takagi; K Iwabuchi; C Iwabuchi; Y Nakamaru; S Maguchi; R Ohwatari; Y Furuta; S Fukuda; S Joyce; K Onoé
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

2.  Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.

Authors:  Li Zhou; Kai Li; Yu-Ling Shi; Iltefat Hamzavi; Tian-Wen Gao; Marsha Henderson; Richard H Huggins; Oma Agbai; Bassel Mahmoud; Xiaofan Mi; Henry W Lim; Qing-Sheng Mi
Journal:  Pigment Cell Melanoma Res       Date:  2012-07-12       Impact factor: 4.693

3.  TCR Valpha14 natural killer T cells function as effector T cells in mice with collagen-induced arthritis.

Authors:  Y Ohnishi; A Tsutsumi; D Goto; S Itoh; I Matsumoto; M Taniguchi; T Sumida
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

Review 4.  Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans.

Authors:  Leonid S Metelitsa
Journal:  Clin Immunol       Date:  2010-11-20       Impact factor: 3.969

5.  Natural killer T-cell characterization through gene expression profiling: an account of versatility bridging T helper type 1 (Th1), Th2 and Th17 immune responses.

Authors:  Marcus Niemeyer; Alexandre Darmoise; Hans-Joachim Mollenkopf; Karin Hahnke; Robert Hurwitz; Gurdyal S Besra; Ulrich E Schaible; Stefan H E Kaufmann
Journal:  Immunology       Date:  2007-10-04       Impact factor: 7.397

6.  iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity.

Authors:  Everett H Meyer; Marc-André Wurbel; Tracy L Staton; Muriel Pichavant; Matthew J Kan; Paul B Savage; Rosemarie H DeKruyff; Eugene C Butcher; James J Campbell; Dale T Umetsu
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

7.  Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.

Authors:  Melanie J Ragin; Nisebita Sahu; Avery August
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

8.  Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.

Authors:  Liping Song; Tasnim Ara; Hong-Wei Wu; Chan-Wook Woo; C Patrick Reynolds; Robert C Seeger; Yves A DeClerck; Carol J Thiele; Richard Sposto; Leonid S Metelitsa
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

9.  Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.

Authors:  Richard A Urbanowicz; Jonathan R Lamb; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  Respir Res       Date:  2010-06-11

10.  Altered effector function of peripheral cytotoxic cells in COPD.

Authors:  Richard A Urbanowicz; Jonathan R Lamb; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  Respir Res       Date:  2009-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.